Frédéric Mourlane

Title: Frédéric Mourlane: Innovator in Antitumoral Therapeutics

Introduction

Frédéric Mourlane is a notable inventor based in Olten, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules with antitumoral activity. His innovative work has led to the filing of multiple patents, showcasing his commitment to advancing medical science.

Latest Patents

Mourlane holds 2 patents that focus on groundbreaking therapeutic approaches. One of his latest patents is titled "Binding molecules with antitumoral activity." This invention relates to a binding molecule that specifically targets two different epitopes of an antigen expressed on tumor cells. The binding molecule consists of a first binding (poly)peptide derived from Fyn SH3 and a second binding (poly)peptide that binds to a different epitope of the same antigen. The invention also encompasses a nucleic acid molecule encoding the binding molecule, a vector containing this nucleic acid, and a host cell transformed with the vector. Furthermore, it outlines methods for producing the binding molecule and its applications in pharmaceutical and diagnostic compositions for tumor treatment.

Another significant patent by Mourlane is focused on "IL-17 binding compounds and medical uses thereof." This invention introduces new IL-17 inhibiting polypeptides, along with corresponding fusion proteins and their medical applications. These innovations are poised to contribute to the development of effective treatments for various medical conditions.

Career Highlights

Frédéric Mourlane is currently associated with Covagen AG, a company known for its pioneering work in the field of biopharmaceuticals. His role at Covagen AG allows him to collaborate with other experts in the industry and contribute to the advancement of therapeutic solutions.

Collaborations

Mourlane has worked alongside talented colleagues such as Simon Brack and Julian Bertschinger. Their collaborative efforts have further enhanced the innovative environment at Covagen AG, leading to the development of cutting-edge therapeutic solutions.

Conclusion

Frédéric Mourlane's contributions to the field of biotechnology, particularly in antitumoral therapeutics, highlight his role as a significant inventor. His patents reflect a commitment to improving medical treatments and advancing scientific knowledge. His work continues to inspire innovation in the biopharmaceutical industry.